Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
InflaRx N.V., a Nasdaq-listed biopharmaceutical company specializing in anti-inflammatory therapeutics targeting the complement system, will report its second quarter 2026 financial and operating results on August 6, 2026, before market open. The company focuses on developing treatments like izicopan and vilobelimab for inflammatory and renal disea…
Tvardi Therapeutics has selected ulcerative colitis (UC) as the first clinical indication for its oral STAT3 inhibitor, TTI-109, after positive results from a Phase 1 healthy volunteer study demonstrating immunomodulatory effects on immune cell populations implicated in UC pathogenesis. The company plans to initiate a moderate-to-severe UC clinical…
Mobilicom Limited announced a significant design win with an Israeli defense technology company developing AI-enabled autonomous weapon systems. The company has delivered integrated software and hardware, including cybersecurity software (OS3), electronic warfare resistance (ICE), secure datalinks (SkyHopper), and ground control stations. This desi…
Palvella Therapeutics announced that its Chief Scientific Officer, Dr. Jeffrey Martini, has been invited to provide public comments at an upcoming FDA public workshop focused on drug repurposing. The meeting will address selection criteria and regulatory considerations for advancing repurposed therapies, particularly targeting rare and chronic dise…
Huntington Ingalls Industries jumped sharply in pre-market trading after reporting second-quarter 2026 results that topped consensus and announcing its Newport News Shipbuilding unit was part of a team awarded roughly $76.6 billion in U.S. Navy contract modifications. The company also declared a quarterly cash dividend, while strong results from de…
The Bank of England left its policy rate unchanged at 3.75% following a 6-3 split on the Monetary Policy Committee. In accompanying analysis it published three scenarios - central, milder and adverse - that outline alternative paths for inflation, output, and energy prices through 2029. Markets are pricing a high probability of two rate hikes by Q3…
Alterity Therapeutics announced an FDA End-of-Phase 2 meeting outcome confirming a clear regulatory pathway for its drug ATH434 targeting Multiple System Atrophy (MSA). The FDA accepted a single pivotal Phase 3 trial plus confirmatory evidence to support approval, with Phase 3 trial initiation planned by the end of 2026. The company also reported c…
Hyatt Hotels shares dropped sharply in pre-market trading after the company published its second-quarter 2026 results before the opening bell. The report failed to meet elevated consensus estimates for adjusted EPS and revenue, prompting a nearly 5% pre-open decline as investors reassessed the pace of the company's fee-driven recovery amid a backdr…
Sirius XM shares fell sharply in pre-market trading after the company released its second-quarter 2026 operating and financial results. The stock dropped 5.7% to $30.75, reversing part of a year-to-date rally that had driven the price to a 52-week high in the prior session. Analyst price targets below the pre-earnings level and ongoing subscriber l…
Capricor Therapeutics shares tumbled sharply in pre-market trade after the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee voted 9-3 that the Phase 3 HOPE-3 trial did not provide substantial evidence that deramiocel is effective for treating cardiomyopathy in Duchenne muscular dystrophy. The advisory panel meeting featured a dispute o…
Check Point Software shares tumbled in pre-market trading after the company reported Q2 2026 results that fell short of Street revenue estimates and included a reduction to full-year revenue guidance. The miss came amid recent analyst downgrades and insider selling, and overshadowed a product announcement for an AI-focused network firewall. The dro…
Norwegian Cruise Line Holdings (NCLH) plunged in pre-market trading after reporting second-quarter 2026 results that combined an earnings beat with a revenue shortfall and a material cut to full-year adjusted EPS guidance. Investors focused on guidance of about $1.50 for 2026, below the Street estimate of $1.67, while management flagged continued d…
Crocs Inc. shares tumbled in pre-market trading after the company posted its Q2 2026 results and reiterated guidance that disappointed the market. The decline centered on continued weakness at the HEYDUDE brand, tariff-driven margin headwinds and forward guidance that left investors unconvinced, triggering a sell-the-news reaction after a strong ru…
Cinemark Holdings reported second-quarter 2026 results that surpassed consensus on both earnings and revenue, driven by a record-setting domestic summer box office. The company posted $1.19 per share in earnings on $1.09 billion of revenue, beating estimates of about $1.02 and $1.03 billion, respectively. The news, coupled with an analyst price-tar…
Meta's core advertising business remains the profit engine that can finance aggressive AI and Reality Labs investments. The stock is down from its highs, trading at a reasonable multiple for a cash-generative ad giant with optionality in AI. This trade idea outlines a long-term (180 trading days) buy with clear entry, target, and stop levels while …
Brazilian President Luiz Inacio Lula da Silva confirmed his government denied visas to two officials from the United States, saying they were being sent to interfere in Brazil’s upcoming general election in October. Brazilian authorities have said the officials planned to cast doubt on the integrity of the electoral system. A U.S. State Department …
The Bank of England held its key interest rate at 3.75% on Thursday while warning that higher energy prices pose an upside risk to inflation and that policy may need to tighten further to ensure inflation returns to 2%. Three members dissented, preferring a 25 basis-point rise to 4%, reflecting debate over how persistent energy costs will feed thro…
Quanta Services jumped 12.1% in pre-market trading after releasing its second-quarter 2026 results before the market opened, outperforming Street expectations for both EPS and revenue. The move built on a recent streak of quarterly beats and was reinforced by an otherwise constructive analyst backdrop, even as a prior downgrade had weighed on the s…
Yum! Brands opened lower in pre-market trading after reporting second-quarter 2026 results that missed consensus on both adjusted EPS and revenue. The shortfall arrived amid an ongoing Cyclospora outbreak tied to iceberg lettuce served at Taco Bell that has depressed customer traffic and prompted analysts to trim full-year forecasts. Market indices…
Xerox shares leapt 22.4% in pre-open trading after the company reported a return to profitability in the second quarter of 2026, posted double-digit year-over-year revenue growth, and raised its fiscal 2026 outlook. The quarter included a $105 million pre-tax benefit tied to IEEPA tariff receivables and showed an adjusted profit versus an adjusted …
The Bank of England's Monetary Policy Committee voted 6-3 to keep Bank Rate at 3.75%, with a majority opting to wait for clearer evidence on energy-driven inflation and second-round effects. Three members advocated an immediate increase to 4% to address upside risks tied to geopolitical tensions and commodity volatility.
Anfield Energy Inc. announced the pricing of a $6 million underwritten public offering of common shares at $4.00 per share, with potential additional shares via over-allotment option. The proceeds will support capital commitments across its U.S.-based uranium and vanadium assets including the Shootaring Canyon Mill and Velvet-Wood Project. The offe…
Check Point Software Technologies shares tumbled 9.5% in pre-market trading after the company reported Q2 2026 results. Adjusted EPS beat expectations at $2.55 versus $2.45 consensus, but revenue came in at $674 million, just below the $675.43 million estimate. Management lowered full-year 2026 revenue guidance, pointing to persistent weakness in f…
Amneal Pharmaceuticals jumped roughly 10% in pre-market trading after reporting a stronger-than-expected second quarter. The Bridgewater, New Jersey-based company beat revenue and adjusted EPS forecasts, raised its full-year guidance for the second time in 2026, and highlighted a pending biosimilars-related transaction as a strategic growth avenue.…
Alternative asset manager Blue Owl reported a rise in adjusted distributable earnings per share for the second quarter and a 12% year-over-year increase in assets under management to $319 billion. Fee-related earnings improved, while new capital commitments and private wealth inflows declined versus the prior-year quarter. The firm continues to man…
